SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-12-004959
Filing Date
2012-11-08
Accepted
2012-11-08 16:30:30
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2012 a102912110q.htm 10-Q 1002143
2 ex31_1.htm EX-31.1 14757
3 ex31_2.htm EX-31.2 14734
4 ex32_1.htm EX-32.1 6429
5 ex32_2.htm EX-32.2 5940
  Complete submission text file 0001214659-12-004959.txt   5218731

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS anth-20120930.xml EX-101.INS 736408
7 EXHIBIT 101.SCH anth-20120930.xsd EX-101.SCH 43890
8 EXHIBIT 101.CAL anth-20120930_cal.xml EX-101.CAL 40444
9 EXHIBIT 101.DEF anth-20120930_def.xml EX-101.DEF 100354
10 EXHIBIT 101.LAB anth-20120930_lab.xml EX-101.LAB 542060
11 EXHIBIT 101.PRE anth-20120930_pre.xml EX-101.PRE 239447
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 121190428
SIC: 2834 Pharmaceutical Preparations